Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
KalVista Pharmaceuticals	KALV	18. nov 2024	9.30	-2.00
Kamada	KMDA	18. nov 2024	5.95	+2.41
Kandi Technologies Group	KNDI	18. nov 2024	1.12	-10.40
Kanzhun ADR	BZ	18. nov 2024	13.78	+2.53
Karat Packaging	KRT	18. nov 2024	29.20	-0.95
Karooooo	KARO	18. nov 2024	39.78	+0.45
Kartoon Studios	TOON	18. nov 2024	0.77	-0.26
Karyopharm Therapeutics	KPTI	18. nov 2024	0.79	-2.40
Katapult	KPLT	18. nov 2024	6.16	-7.03
Kayne Anderson BDC	KBDC	18. nov 2024	16.38	-1.50
Kayne Anderson Energy Infrastructure Fund	KYN	18. nov 2024	12.91	+1.81
Kazia Therapeutics ADR	KZIA	18. nov 2024	5.08	+11.16
KB Financial Group ADR	KB	18. nov 2024	65.26	+1.75
KB Home	KBH	18. nov 2024	77.28	-1.59
KBR	KBR	18. nov 2024	58.15	-0.85
KBW Bank Powershares	KBWB	18. nov 2024	69.24	-0.03
KBW High Div Yield Financial Powershares	KBWD	18. nov 2024	15.12	-0.59
KBW Prem Yield Equity REIT Powershares	KBWY	18. nov 2024	19.34	-0.46
KBW Prop & Casuality Insur Powershares	KBWP	18. nov 2024	121.95	+0.40
KBW Regional Banking Powershares	KBWR	18. nov 2024	65.11	-0.21
KE Holdings	BEKE	18. nov 2024	20.55	+5.28
Kearny Financial	KRNY	18. nov 2024	8.12	-1.10
Keen Vision Acquisition	KVAC	18. nov 2024	10.87	0.00
Keen Vision Acquisition	KVACU	18. nov 2024	10.99	0.00
Kellanova	K	18. nov 2024	80.60	+0.04
Kelly Services A	KELYA	18. nov 2024	14.16	-1.60
Kelly Services B	KELYB	18. nov 2024	16.07	0.00
Kemper	KMPR	18. nov 2024	70.53	-1.00
Kennametal	KMT	18. nov 2024	28.20	-0.91
Kennedy-Wilson	KW	18. nov 2024	10.75	-0.65

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.